Study on the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Implantation Combined With Bypass Grafting in Patients With Coronary Artery Disease and Ischemic Cardiomyopathy.
Latest Information Update: 13 Jul 2020
At a glance
- Drugs CLXR 001 (Primary)
- Indications Cardiomyopathies; Coronary artery disease
- Focus Adverse reactions
- 13 Jul 2020 New trial record